Cargando…
Regulation of ferroptosis‐related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer
BACKGROUND: Drug resistance has led to the failure of immunotherapy in triple negative breast cancer patients. Here we aimed to explore the mechanisms of drug resistance in patients in order to enhance their response to immunotherapy. METHODS: We downloaded publicly available single‐cell RNA‐sequenc...
Autores principales: | Liu, Zheming, He, Songjiang, Huang, Zhou, Liu, Jiahui, Gong, Yiping, Yao, Yi, Zhang, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693945/ https://www.ncbi.nlm.nih.gov/pubmed/37830388 http://dx.doi.org/10.1111/1759-7714.15128 |
Ejemplares similares
-
Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015) -
Advances in NKT cell Immunotherapy for Glioblastoma
por: Pyaram, Kalyani, et al.
Publicado: (2018) -
Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020) -
PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis
por: Wang, Zhe, et al.
Publicado: (2023) -
CD8(+) T cells regulate tumor ferroptosis during cancer immunotherapy
por: Wang, Weimin, et al.
Publicado: (2019)